A U.S.-based biotechnology company specializes in spatial biology, offering solutions that enable scientists to visualize molecular interactions in 3D, providing insights into gene and protein expression within tissue structures.
The US market was the primary launch focus for the client’s new technology. Europe was identified as the next strategic expansion, and the company sought an entry point that would maximize impact while minimizing risk.
Through a dedicated sales outsourcing strategy, the technology was successfully introduced to the European life sciences market. A specialized team was deployed across Europe to drive market entry, build brand awareness, and establish a strong commercial presence.
Over 15 months, a robust sales pipeline generating over $1M in revenue was build. The technology was presented to academic centers of excellence and key industry players. Additional technology evaluations were coordinated to drive adoption and validate performance in real-world settings.
Whether you’re entering the market or scaling your presence, we’re here to turn your innovation into commercial success.
